Innovia's most valuable asset is its people. With more than 100 U.S. patents, Innovia’s chemists and engineers have been responsible for over $15 billion in revenue throughout their careers; more importantly, they have saved or improved millions of lives. Innovia's employees come from diverse industry backgrounds and experiences enabling the Company to create novel solutions through collaboration across a wide spectrum of technologies. For example, the valve platform that was used to seal the Orbital Tissue Expander for oculoplastic applications is a technology that was used long ago for the first generation of breast implants. This type of collaboration produces tried and true technology that works.

Innovia maintains close ties to the community and continues to work with an extensive network of laboratories, physicians, and hospitals to research, develop, and manufacture innovative device solutions. In addition to its commercialized products, Innovia has an extensive pipeline of products that leverage its superior materials platform. These products span many sectors, maintain proprietary positions protected by intellectual property, and are available for sale, license, distribution, etc. With ISO 13485 certification, Innovia also services the medical device industry by performing contract manufacturing work/OEM, designing and developing devices and polymers, and conducting research and development programs for clients.

Please contact Innovia with any inquiries.